Naturalendo Tech Co. Ltd. (168330) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Naturalendo Tech Co. Ltd. (168330:KRX), powered by AI.

Current Price
₩2,850
P/E Ratio
-28.1
Market Cap
90.5B
Sector
Healthcare
What is the Naturalendo Tech Co. Ltd. stock price forecast?

Naturalendo Tech Co. Ltd. is currently trading at ₩2,850. View real-time AI analysis on Alpha Lenz.

What is Naturalendo Tech Co. Ltd. insider trading activity?

View the latest insider trading data for Naturalendo Tech Co. Ltd. on Alpha Lenz.

What is Naturalendo Tech Co. Ltd.'s P/E ratio?

Naturalendo Tech Co. Ltd.'s P/E ratio is -28.1.

Naturalendo Tech Co. Ltd.

KRX · 168330
₩2,850+455(+19.00%)Market closedKRX regular session 09:00–15:30 KST
Ask about Naturalendo Tech Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Naturalendo Tech Co. Ltd. trades at a P/E of -28.1 (undervalued) with modest ROE of -12.6%. 3Y revenue CAGR of 16.8% highlights clear growth momentum.

Ask for details

Company Overview

Naturalendo Tech Co. Ltd. is a biotechnology company that primarily focuses on the development and commercialization of innovative healthcare solutions. Its primary function is to advance medical research and provide novel treatments and technologies aimed at improving patient outcomes. The company is actively engaged in the fields of drug development, medical devices, and therapeutic procedures, which have significant implications in various sectors, including pharmaceuticals and healthcare services. Founded with a mission to harness the power of biotechnology, Naturalendo Tech Co. Ltd. serves a diverse range of stakeholders, from patients and healthcare providers to research institutions. Its portfolio includes a pipeline of proprietary drugs and state-of-the-art medical instruments, underscoring its commitment to tackling unmet medical needs. Within the financial markets, the company is recognized for its potential to drive innovation and contribute to the evolving landscape of the biomedical industry. By leveraging cutting-edge science and technology, Naturalendo Tech Co. Ltd. plays a pivotal role in providing advanced healthcare solutions that can enhance quality of life globally.

CEO김희도
SectorHealthcare
IndustryBiotechnology
Employees74

Company Statistics

FY 2025

Profile

₩90,501,465,000Market Cap
₩22,226,566,080Revenue
31.75MShares Out
74Employees

Margins

43.18%Gross
-10.66%EBITDA
-14.82%Operating
-16.29%Pre-Tax
-16.29%Net

Valuation

-28.09P/E
3.77P/B
4.07EV/Sales
-41.70EV/EBITDA
-15.47P/FCF

Growth (CAGR)

16.80%Rev 3Yr
10.90%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-10.47%ROA
-12.59%ROE
-9.68%ROIC

Financial Health

₩296,180,450Cash & Cash Equivalents
₩12,285,967,960Net Debt
54.13%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Naturalendo Tech Co. Ltd. (ticker: 168330) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 74 employees. Market cap is $90.5B.

The current price is ₩2,850 with a P/E ratio of -28.09x and P/B of 3.77x.

ROE is -12.59% and operating margin is -14.82%. Annual revenue is $22.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Naturalendo Tech Co. Ltd. (168330) Stock Forecast 2026 ₩2,850 — Price, Financials & Analyst Targets | Alpha Lenz